144 related articles for article (PubMed ID: 476306)
1. Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas.
Ferraris AM; Giuntini P; Gaetani GF
Blood; 1979 Oct; 54(4):928-32. PubMed ID: 476306
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of serum lactic dehydrogenase in non-Hodgkin's lymphoma.
Hagberg H; Siegbahn A
Scand J Haematol; 1983 Jul; 31(1):49-56. PubMed ID: 6867608
[TBL] [Abstract][Full Text] [Related]
3. Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin's lymphoma.
Endrizzi L; Fiorentino MV; Salvagno L; Segati R; Pappagallo GL; Fosser V
Eur J Cancer Clin Oncol; 1982 Oct; 18(10):945-9. PubMed ID: 6891644
[TBL] [Abstract][Full Text] [Related]
4. Serum LDH values in childhood acute leukemias and non-Hodgkin's lymphoma.
Suarez CR; Andreeff M; Miller DR
Med Pediatr Oncol; 1984; 12(2):89-92. PubMed ID: 6583472
[TBL] [Abstract][Full Text] [Related]
5. Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.
Fasola G; Fanin R; Gherlinzoni F; Galieni P; Taruscio D; Frezza G; Mazza P; Pileri S; Baccarani M
Acta Haematol; 1984; 72(4):231-8. PubMed ID: 6438991
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma.
Schneider RJ; Seibert K; Passe S; Little C; Gee T; Lee BJ; Miké V; Young CW
Cancer; 1980 Jul; 46(1):139-43. PubMed ID: 6992974
[TBL] [Abstract][Full Text] [Related]
7. Lactate dehydrogenase levels in cellular extracts of human malignant lymphomas.
Vezzoni MA; Lucchini R; Giardini R; Raineri M; Murone M; Vezzoni P
Tumori; 1983 Aug; 69(4):279-82. PubMed ID: 6623651
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis.
Lu R; Jiang M; Chen Z; Xu X; Hu H; Zhao X; Gao X; Guo L
PLoS One; 2013; 8(9):e74853. PubMed ID: 24086384
[TBL] [Abstract][Full Text] [Related]
9. [Significance of clinical and laboratory chemical parameters for the course and prognosis of non-Hodgkin's lymphomas].
Steinke B; Mau J
Klin Wochenschr; 1986 May; 64(10):445-51. PubMed ID: 2425124
[TBL] [Abstract][Full Text] [Related]
10. A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
Swan F; Velasquez WS; Tucker S; Redman JR; Rodriguez MA; McLaughlin P; Hagemeister FB; Cabanillas F
J Clin Oncol; 1989 Oct; 7(10):1518-27. PubMed ID: 2674337
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].
Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ
Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885
[TBL] [Abstract][Full Text] [Related]
12. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
Vaccher E; Tirelli U; Spina M; Talamini R; Errante D; Simonelli C; Carbone A
J Clin Oncol; 1996 Aug; 14(8):2217-23. PubMed ID: 8708710
[TBL] [Abstract][Full Text] [Related]
13. Intracellular lactic dehydrogenase and phosphohexose isomerase activity in leukaemia and malignant lymphoma.
Ho AD; Fiehn W; Hunstein W
Br J Haematol; 1982 Apr; 50(4):637-45. PubMed ID: 7066211
[TBL] [Abstract][Full Text] [Related]
14. Prognostic parameters in low-grade non-Hodgkin's lymphomas.
Zemunik T; Vucković J; Forenpoher G; Knezević N; Stula N; Dubravcić M; Ribicić I; Rozga A
Neoplasma; 1997; 44(1):13-7. PubMed ID: 9201275
[TBL] [Abstract][Full Text] [Related]
15. Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma.
Dumontet C; Drai J; Bienvenu J; Berard EN; Thieblemont C; Bouafia F; Bayle F; Moullet I; Salles G; Coiffier B
Leukemia; 1999 May; 13(5):811-7. PubMed ID: 10374888
[TBL] [Abstract][Full Text] [Related]
16. Serum lactate dehydrogenase isoenzyme pattern in non-Hodgkin's lymphomas.
Ricerca BM; Storti S; Campisi S; Pagano L; Dalla Torre F; Marra R; Amato A; Mango G; Bizzi B
Int J Biol Markers; 1988; 3(4):237-42. PubMed ID: 3235851
[TBL] [Abstract][Full Text] [Related]
17. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
Benboubker L; Valat C; Linassier C; Cartron G; Delain M; Bout M; Fetissof F; Lefranq T; Lamagnere JP; Colombat P
Ann Oncol; 2000 Nov; 11(11):1485-91. PubMed ID: 11142490
[TBL] [Abstract][Full Text] [Related]
18. Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
Danieu L; Wong G; Koziner B; Clarkson B
Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438
[TBL] [Abstract][Full Text] [Related]
19. Lactate dehydrogenase isoenzyme activity in malignant haematological diseases.
Paule B; Francoual J; Lindenbaum A; Derrieux C; Russo C; Gerbet D; Leluc R
Biomed Pharmacother; 1984; 38(1):62-5. PubMed ID: 6590095
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.
Warzocha K; Salles G; Bienvenu J; Barbier Y; Bastion Y; Doche C; Rieux C; Coiffier B
Leukemia; 1997 Apr; 11 Suppl 3():441-3. PubMed ID: 9209418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
